These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 8412313)

  • 61. Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction.
    van Dongen JJ; Breit TM; Adriaansen HJ; Beishuizen A; Hooijkaas H
    Leukemia; 1992; 6 Suppl 1():47-59. PubMed ID: 1548936
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clonal evolution of immunoglobulin heavy chain rearrangements in childhood B-precursor acute lymphoblastic leukemia after engraftment in SCID mice.
    Steenbergen EJ; Verhagen OJ; Nibbering CP; van den Berg H; van Leeuwen EF; Behrendt H; von dem Borne AE; van der Schoot CE
    Leukemia; 1996 Sep; 10(9):1471-8. PubMed ID: 8751465
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparative analysis of T-cell receptor gene rearrangements at diagnosis and relapse of T-cell acute lymphoblastic leukemia (T-ALL) shows high stability of clonal markers for monitoring of minimal residual disease and reveals the occurrence of second T-ALL.
    Szczepański T; van der Velden VH; Raff T; Jacobs DC; van Wering ER; Brüggemann M; Kneba M; van Dongen JJ
    Leukemia; 2003 Nov; 17(11):2149-56. PubMed ID: 14576730
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Molecular detection of acute lymphoblastic leukaemia in boys with testicular relapse.
    Lal A; Kwan E; al Mahr M; Zhou L; Ferrara D; Tobias V; O'Gorman Hughes D; Haber M; Norris MD; Marshall GM
    Mol Pathol; 1998 Oct; 51(5):277-81. PubMed ID: 10193523
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Myeloid surface antigen-positive acute lymphoblastic leukemia (My+ ALL): immunophenotypic, ultrastructural, cytogenetic, and molecular characteristics.
    Childs CC; Hirsch-Ginsberg C; Walters RS; Andersson BS; Reuben J; Trujillo JM; Cork A; Stass SA; Freireich EJ; Zipf TF
    Leukemia; 1989 Nov; 3(11):777-83. PubMed ID: 2811478
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Childhood B lineage acute lymphoblastic leukemia clonality study by the polymerase chain reaction.
    Scrideli CA; Simoes AL; Defavery R; Bernardes JE; Duarte MH; Tone LG
    J Pediatr Hematol Oncol; 1997; 19(6):516-22. PubMed ID: 9407937
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Diagnosis of canine lymphoid neoplasia using clonal rearrangements of antigen receptor genes.
    Burnett RC; Vernau W; Modiano JF; Olver CS; Moore PF; Avery AC
    Vet Pathol; 2003 Jan; 40(1):32-41. PubMed ID: 12627711
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A competitive PCR-based method using TCRD, TCRG and IGH rearrangements for rapid detection of patients with high levels of minimal residual disease in acute lymphoblastic leukemia.
    Guidal C; Vilmer E; Grandchamp B; Cavé H
    Leukemia; 2002 Apr; 16(4):762-4. PubMed ID: 11960365
    [No Abstract]   [Full Text] [Related]  

  • 69. PCR-heteroduplex analysis of TCR gamma, delta and TAL-1 deletions in T-acute lymphoblastic leukemias: implications in the detection of minimal residual disease.
    Nirmala K; Rajalekshmy KR; Raman SG; Shanta V; Rajkumar T
    Leuk Res; 2002 Apr; 26(4):335-43. PubMed ID: 11839375
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Residual disease detection using fluorescent polymerase chain reaction at 20 weeks of therapy predicts clinical outcome in childhood acute lymphoblastic leukemia.
    Evans PA; Short MA; Owen RG; Jack AS; Forsyth PD; Shiach CR; Kinsey S; Morgan GJ
    J Clin Oncol; 1998 Nov; 16(11):3616-27. PubMed ID: 9817283
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clonal evolution as judged by immunoglobulin heavy chain gene rearrangements in relapsing precursor-B acute lymphoblastic leukemia.
    Rosenquist R; Thunberg U; Li AH; Forestier E; Lönnerholm G; Lindh J; Sundström C; Sällström J; Holmberg D; Roos G
    Eur J Haematol; 1999 Sep; 63(3):171-9. PubMed ID: 10485272
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Posttherapy surveillance of B-cell precursor acute lymphoblastic leukemia. Value of polymerase chain reaction and limitations of flow cytometry.
    Kallakury BV; Hartmann DP; Cossman J; Gootenberg JE; Bagg A
    Am J Clin Pathol; 1999 Jun; 111(6):759-66. PubMed ID: 10361511
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Detection of clonality in childhood B-lineage acute lymphoblastic leukaemia by the polymerase chain reaction.
    Potter MN; Steward CG; Maitland NJ; Oakhill A
    Leukemia; 1992 Apr; 6(4):289-94. PubMed ID: 1588791
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Long-term follow-up of minimal residual disease in childhood acute lymphoblastic leukemia patients by polymerase chain reaction analysis of multiple clone-specific or malignancy-specific gene markers.
    Kuang S; Gu L; Dong S; Cao Q; Xu C; Huang W; Su XY; Huang QH; Xie JX; Chen SJ; Chen Z
    Cancer Genet Cytogenet; 1996 Jun; 88(2):110-7. PubMed ID: 8640718
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Minimal residual disease after intensive induction therapy in childhood acute lymphoblastic leukemia predicts outcome.
    Gruhn B; Hongeng S; Yi H; Hancock ML; Rubnitz JE; Neale GA; Kitchingman GR
    Leukemia; 1998 May; 12(5):675-81. PubMed ID: 9593264
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Immunoglobulin heavy chain gene fingerprinting reveals widespread oligoclonality in B-lineage acute lymphoblastic leukaemia.
    Deane M; Pappas H; Norton JD
    Leukemia; 1991 Oct; 5(10):832-8. PubMed ID: 1961017
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Minimal residual disease in acute lymphoblastic leukemia detected by immune selection and gene rearrangement analysis.
    Bregni M; Siena S; Neri A; Bassan R; Barbui T; Delia D; Bonadonna G; Dalla Favera R; Gianni AM
    J Clin Oncol; 1989 Mar; 7(3):338-43. PubMed ID: 2918330
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sequential monitoring of minimal residual disease in acute lymphoblastic leukemia: 7-year experience in a pediatric hematology/oncology unit.
    Katsibardi K; Moschovi MA; Braoudaki M; Papadhimitriou SI; Papathanasiou C; Tzortzatou-Stathopoulou F
    Leuk Lymphoma; 2010 May; 51(5):846-52. PubMed ID: 20350276
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [A tal-1 deletion as real-time quantitative polymerase chain reaction target for detection of minimal residual disease in T-lineage acute lymphoblastic leukemia].
    Wang L; Zhang LP; Li ZG; Cheng YF; Tian KG; Lu AD
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):170-3. PubMed ID: 15833185
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Presence of leukemic clone-specific immunoglobulin heavy chain rearrangements in neonatal blood spots of children with B-cell precursor acute lymphoblastic leukemia.
    Kacanski N; Kolarovic J; Kostic T; Marjanovic I; Janic D; Pavlovic S; Karan-Djurasevic T
    Int J Lab Hematol; 2024 Apr; 46(2):303-311. PubMed ID: 37929321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.